| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.14▲ | 8.15▲ | 8.14▲ | 8.19▼ | 8.42▼ |
| MA10 | 8.12▲ | 8.10▲ | 8.09▲ | 8.03▲ | 8.21▼ |
| MA20 | 8.09▲ | 8.09▲ | 8.09▲ | 8.37▼ | 8.38▼ |
| MA50 | 8.07▲ | 8.12▲ | 8.03▲ | 8.17▲ | 9.17▼ |
| MA100 | 8.13▲ | 8.00▲ | 8.20▼ | 8.48▼ | 7.17▲ |
| MA200 | 8.00▲ | 8.25▼ | 8.34▼ | 9.10▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.010▲ | 0.014▲ | 0.008▲ | -0.026▼ | N/A |
| RSI | 63.041▲ | 59.898▲ | 57.122▲ | 48.334▼ | N/A |
| STOCH | 90.310▲ | 90.907▲ | 76.681 | 62.423 | 72.644 |
| WILL %R | 0.000▲ | 0.000▲ | -4.000▲ | -56.444 | -40.446 |
| CCI | 121.614▲ | 117.726▲ | 114.356▲ | -7.574 | 7.443 |
|
Monday, February 11, 2019 04:51 AM
Aeglea BioTherapeutics Inc. (Nasdaq: AGLE), an Austin-based biotechnology company developing treatments for rare genetic diseases and cancer, announced plans to raise $60 million with a stock offering ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/02/19 | 7.945 | 8.18 | 7.945 | 8.18 | 59,783 |
| 21/02/19 | 8.15 | 8.16 | 7.94 | 8.06 | 138,915 |
| 20/02/19 | 8.20 | 8.21 | 7.91 | 8.19 | 220,261 |
| 19/02/19 | 8.30 | 8.42 | 8.00 | 8.17 | 144,168 |
| 15/02/19 | 8.19 | 8.45 | 8.03 | 8.35 | 309,203 |
| 14/02/19 | 7.79 | 8.30 | 7.79 | 8.16 | 295,465 |
| 13/02/19 | 7.72 | 7.93 | 7.50 | 7.90 | 552,159 |
| 12/02/19 | 7.81 | 7.85 | 7.521 | 7.66 | 100,275 |
| 11/02/19 | 7.92 | 8.01 | 7.77 | 7.80 | 164,824 |
| 08/02/19 | 7.85 | 8.00 | 7.74 | 7.83 | 209,008 |
|
|
||||
|
|
||||
|
|
||||
|
|